Very nice piece about the duality in biotech currently leading to flat growth in the sector. Hot areas are reaching saturation, while conviction from crossover investors to support early innovation hasn't yet returned. lifescivc.com/2025/01/a-ta...
21.01.2025 17:23 — 👍 3 🔁 0 💬 0 📌 0